1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow IMMUNOe Research Centers: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection Ruconest - Post-Viral Fatigue Syndrome, Post-Viral Disorder (Disorder) | Phase 2 | Completed | IMMUNOe Research Centers | 40 | 2021-01-11 | 2025-08-11 |
COVID-19 (1) · Fatigue Syndrome, Chronic (1)
conestat alfa (1)
United States (1)